Showing 1611-1620 of 2150 results for "".
- Incyte, Novartis to Evaluate JAK Inhibitor Ruxolitinib for Severe COVID-19 Patientshttps://modernod.com/news/incyte-novartis-to-evaluate-jak-inhibitor-ruxolitinib-for-severe-covid-19-patients/2477527/Incyte and Novartis announced that the companies plan to initiate a phase 3 collaborative study to assess ruxolitinib plus standard-of-care, versus standard care alone, in patients suffering from COVID-19-associated cytokine storm. The clinical trial will be sponsored by Incyte in the US, where t
- ImprimisRx Announces Supply Agreement with Vision Center Network of America (VCNA)https://modernod.com/news/imprimisrx-announces-supply-agreement-with-vision-center-network-of-america-vcna/2477342/ImprimisRx announced that it has agreed to a product supply agreement with Vision Center Network of America LLC (VCNA). The agreement will make ImprimisRx a VCNA preferred provider for a variety of surgical formulations, including a portfolio of topical and injectable products. Terms of t
- EMA Grants Two Product Designations to Janssen’s RPGR Gene Therapy for X-Linked Retinitis Pigmentosahttps://modernod.com/news/ema-grants-two-product-designations-to-janssens-rpgr-gene-therapy-for-x-linked-retinitis-pigmentosa/2477338/The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Medicines Agency (EMA) has granted both PRIME (PRIority MEdicines) and Advanced Therapy Medicinal Product (ATMP) designations to the company’s adeno-associated virus (AAV)-RPGR gene t
- Staar Surgical Announces Strategic Cooperation Agreement with Senshinkai Eye Institute in Japanhttps://modernod.com/news/staar-surgical-announces-strategic-cooperation-agreement-with-senshinkai-eye-institute-in-japan/2477276/Staar Surgical announced that it entered a strategic cooperation agreement with Senshinkai Eye Institute (SEI), an eye care group with five locations in Japan. The agreement includes volume commitments for the company’s implantable collamer lenses (ICLs), ICL surgeon training and certification, t
- AAO: Survey Reveals Most Americans Know a Lot Less About Eye Health Than They Think They Dohttps://modernod.com/news/aao-survey-reveals-most-americans-know-a-lot-less-about-eye-health-than-they-think-they-do/2477222/A survey conducted by The Harris Poll has uncovered key gaps in American’s knowledge of eye health, and what they don’t know is putting them at risk of vision loss, according to an AAO news release. With the number of people affected by potentially blinding eye diseases expected to do
- EnChroma Introduces Line of Lenses for Low Vision and Age-Related Eye Conditionshttps://modernod.com/news/enchroma-introduces-line-of-lenses-for-low-vision-and-age-related-eye-conditions/2477199/EnChroma unveiled the “EnChroma Lx Series for Low Vision and Age-Related Eye Conditions,” a product line to address a rapidly growing category of visual challenges worldwide. The new line will be showcased at the Opti Munich 2020 International Trade Show for Optics and Design t
- Alcon Announces Findings from IRIS Registry Analyses on Real-World Cataract Patients at AAOhttps://modernod.com/news/alcon-announces-findings-from-iris-registry-analyses-on-real-world-cataract-patients-at-aao/2477012/Alcon announced findings from the American Academy of Ophthalmology IRIS Registry (Intelligent Research in Sight) that support the clinical value of the AcrySof platform. The IRIS Registry was used to assess characteristics and complications of IOL implantation after cataract surgery, according t
- Aerie Pharmaceuticals Submits Prior Approval Supplement to FDA to Allow Production of Rocklatan in its Athlone Ireland Facilityhttps://modernod.com/news/aerie-pharmaceuticals-submits-prior-approval-supplement-to-fda-to-allow-production-of-rocklatan-in-its-athlone-ireland-facility/2476897/Aerie Pharmaceuticals announced the submission of a prior approval supplement (PAS) to the FDA to permit production of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for sale in the United States in Aerie’s new manufacturing plant in Athlone, Ireland. “Along with t
- Registration Now Open for International Sports Vision Association Annual Conferencehttps://modernod.com/news/registration-now-open-for-international-sports-vision-association-annual-conference/2476869/Registration is now open for Beyond 20/20, the 4th annual International Sports Vision Association (ISVA) conference, February 6-8, 2020, at the Bahia Resort Hotel in San Diego, California. “Sports Vision, the science of helping athletes reach peak levels of performance through t
- Macular Degeneration Conference Series in the Spotlighthttps://modernod.com/news/macular-degeneration-conference-series-in-the-spotlight/2476865/Part of the 2019 Macular Degeneration Association Educational Conference Series will take place on Saturday, September 21, at the Doubletree Chicago North Shore Conference Center Skokie, Illinois. The conference, “Eyes on Sight,” is aimed to deliver the most up-to-date research regarding t